Fortress Biotech Revenue vs. Shares Owned By Institutions
| FBIOP Preferred Stock | USD 6.58 0.67 11.34% |
For Fortress Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Fortress Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Fortress Biotech Pref utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Fortress Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Fortress Biotech Pref over time as well as its relative position and ranking within its peers.
Fortress |
Fortress Biotech Pref Shares Owned By Institutions vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Fortress Biotech's current stock value. Our valuation model uses many indicators to compare Fortress Biotech value to that of its competitors to determine the firm's financial worth. Fortress Biotech Pref is rated # 3 in revenue category among its peers. It is rated below average in shares owned by institutions category among its peers . The ratio of Revenue to Shares Owned By Institutions for Fortress Biotech Pref is about 38,217,222 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fortress Biotech's earnings, one of the primary drivers of an investment's value.Fortress Revenue vs. Competition
Fortress Biotech Pref is rated # 3 in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 192.2 Million. Fortress Biotech totals roughly 68.79 Million in revenue claiming about 36% of equities under Health Care industry.
Fortress Shares Owned By Institutions vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Fortress Biotech |
| = | 68.79 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Fortress Biotech |
| = | 1.80 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Fortress Shares Owned By Institutions Comparison
Fortress Biotech is currently under evaluation in shares owned by institutions category among its peers.
Fortress Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Fortress Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Fortress Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Fortress Biotech's change in net profit over the period of time. It can combine multiple indicators of Fortress Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.
Fortress Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Fortress Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Fortress Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Fortress Biotech's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Fortress Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Use Investing Themes to Complement your Fortress Biotech position
In addition to having Fortress Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Single Stock ETFs Thematic Idea Now
Single Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Single Stock ETFs theme has 99 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Single Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.